Skip to main content
ZEVRA THERAPEUTICS, INC. logo

ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ZVRA ISIN · US4884452065 LEI · 254900CU6T74V18Y1W18 US Manufacturing
Filings indexed 830 across all filing types
Latest filing 2022-07-08 Major Shareholding Noti…
Country US United States of America
Listing US ZVRA

About ZEVRA THERAPEUTICS, INC.

https://zevra.com/

Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2022
Major Shareholding Notification
2022-07-08 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 28, 2022. It reports the submission of matters to a vote of security holders at the company's 2022 Annual Meeting of Stockholders. The content includes detailed voting results for director elections and ratification of the independent auditor. This matches the description of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4308 characters, which is short but contains actual voting results, not just an announcement of a report. Therefore, it is not a Report Publication Announcement (RPA). The focus on voting results at the annual meeting aligns precisely with the DVA category.
2022-07-01 English
FORM 4
Director's Dealing
2022-06-30 English
FORM 4
Director's Dealing
2022-06-30 English
FORM 4
Director's Dealing
2022-06-30 English
FORM 4
Director's Dealing
2022-06-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.